APOE & Genetic Risk Assessment
Neuroinflammation Pathways
Mitochondrial Function
Comprehensive genetic testing for Alzheimer’s risk, neuroinflammation, detoxification, methylation, and brain resilience.
Influences brain lipid transport, amyloid clearance, inflammation, and cardiovascular/metabolic risk
Evaluates inflammation control, oxidative stress, and detoxification pathways
Influences amyloid clearance, tau phosphorylation, lipid metabolism, and neuronal repair
Most approaches focus on late-stage symptoms. This panel identifies early risk factors—years before symptoms appear—so you can take proactive steps.
Most patients complete this test using a simple cheek swab. Blood collection may also be available.
Results typically return within 2–3 weeks.
No. APOE4 increases risk but does not determine outcome; lifestyle and preventive strategies can reduce risk.
Yes. Understanding genetic risk allows targeted interventions to support brain health.
Yes. Local patients may receive concierge collection. Remote patients receive a mail-in kit.
